Home › Free Stock Grades › INVA
Innoviva, Inc. (INVA) Stock Grade
INVA · Healthcare
A+
Market Cap
$1.3B
P/E Ratio
5.0
Revenue Growth (YoY)
+18.5%
Net Margin
63.8%
Return on Equity
23.1%
Dividend Yield
None
About Innoviva, Inc.'s fundamentals
Innoviva is a biotech company with a $1.3 billion market capitalization that demonstrates strong profitability metrics, including a net margin of 63.8% and a return on equity of 23.1%. The company is growing revenues at an 18.5% year-over-year rate while trading at a P/E ratio of 5.0, suggesting a relatively low valuation relative to earnings. With no dividend payment, the company appears to be reinvesting profits into operations or maintaining cash reserves rather than returning capital to shareholders.